Can patents on diagnostic tests survive in the US?

In March 2012 it was controversially held by the US Supreme Court in Mayo Collaborative Services v Prometheus Laboratories Inc. (2012) that a “relationship” between the concentrations of blood metabolites and response to a therapeutic drug, claimed in patents owned by Prometheus Laboratories Inc was not patentable because it represented a “principle of nature”. The Court stated